Annual Accounts Receivable
$0.00
-$96.00 K-100.00%
December 31, 2023
Summary
- As of February 8, 2025, CYCN annual accounts receivable is $0.00, with the most recent change of -$96.00 thousand (-100.00%) on December 31, 2023.
- During the last 3 years, CYCN annual accounts receivable has fallen by -$127.00 thousand (-100.00%).
- CYCN annual accounts receivable is now -100.00% below its all-time high of $1.47 million, reached on December 31, 2019.
Performance
CYCN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$44.00 K
NaN%
September 30, 2024
Summary
- As of February 8, 2025, CYCN quarterly accounts receivable is $44.00 thousand
- Over the past year, CYCN quarterly accounts receivable has increased by +$44.00 thousand (+100.00%).
- CYCN quarterly accounts receivable is now -97.63% below its all-time high of $1.86 million, reached on June 30, 2019.
Performance
CYCN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CYCN Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | +100.0% |
| 3 y3 years | -100.0% | -72.2% |
| 5 y5 years | 0.0% | -96.9% |
CYCN Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -80.6% | -100.0% |
| 5 y | 5-year | -100.0% | at low | -97.0% | -100.0% |
| alltime | all time | -100.0% | at low | -97.6% | -100.0% |
Cyclerion Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $44.00 K(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $96.00 K(0.0%) |
| Dec 2022 | $96.00 K(-4.0%) | $96.00 K(-57.7%) |
| Sep 2022 | - | $227.00 K(0.0%) |
| Jun 2022 | - | $227.00 K(0.0%) |
| Mar 2022 | - | $227.00 K(+127.0%) |
| Dec 2021 | $100.00 K | $100.00 K(-36.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $158.00 K(>+9900.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $127.00 K(-91.4%) | $127.00 K(-68.3%) |
| Sep 2020 | - | $400.00 K(-46.7%) |
| Jun 2020 | - | $751.00 K(-26.8%) |
| Mar 2020 | - | $1.03 M(-30.4%) |
| Dec 2019 | $1.47 M(>+9900.0%) | $1.47 M(+2.4%) |
| Sep 2019 | - | $1.44 M(-22.5%) |
| Jun 2019 | - | $1.86 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Cyclerion Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual accounts receivable year-on-year change?
- What is Cyclerion Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly accounts receivable year-on-year change?
What is Cyclerion Therapeutics annual accounts receivable?
The current annual accounts receivable of CYCN is $0.00
What is the all time high annual accounts receivable for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual accounts receivable is $1.47 M
What is Cyclerion Therapeutics annual accounts receivable year-on-year change?
Over the past year, CYCN annual accounts receivable has changed by -$96.00 K (-100.00%)
What is Cyclerion Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of CYCN is $44.00 K
What is the all time high quarterly accounts receivable for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly accounts receivable is $1.86 M
What is Cyclerion Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, CYCN quarterly accounts receivable has changed by +$44.00 K (+100.00%)